Medtronic introduces a software-centered Smart MDI system that connects insulin pens and glucose sensors to deliver algorithm-driven guidance for injection-based diabetes therapy.

The versatile and modular Hugo robotic platform receives US clearance, offering surgeons greater choice and expanding access to minimally invasive procedures across urology departments.

Medtronic launches the MiniMed 780G with the Instinct sensor, offering automated insulin adjustments and extended-wear CGM for smarter diabetes management.

The minimally invasive tibial neuromodulation device offers 15-year battery life, MRI compatibility, and automatic therapy delivery, reducing patient burden while restoring bladder-brain communication for lasting symptom relief.

Medtronic’s Hugo robotic-assisted surgery system achieved 100% surgical success in inguinal and ventral hernia repair, meeting primary safety and effectiveness endpoints in the Enable Hernia Repair study.

Medtronic’s new disposable glucose sensor offers enhanced comfort and accuracy for diabetes management, now cleared for use with the MiniMed 780G insulin pump system.

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever.

The Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.

The envisioned partnership will be an evolution of the AiBLE ecosystem which integrates connected care and predictive technology to advance surgery.

SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results.